Discovery of novel potential KIT inhibitors for the treatment of gastrointestinal stromal tumor
Guardado en:
Autores principales: | Jiang Lili, Zhang Zhongmin, Wang Zhen, Liu Yong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/06908f9076994d59b34e1f1f8f05d716 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
<i>In Silico</i> Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-like Protease: Pharmacophoric Features, Molecular Docking, ADMET, Toxicity and DFT Studies
por: Mohamed S. Alesawy, et al.
Publicado: (2021) -
Pharmakinetics studies, molecular docking and discovery of anti- proliferative agents and its targeting EGFR inhibitors
por: Palanisamy Prakash, et al.
Publicado: (2022) -
Gastrointestinal Stromal Tumors (GISTs): Single Center Experience Observed in a Small Series of Cases
por: Manterola,Carlos, et al.
Publicado: (2016) -
Identification of Novel Antagonists Targeting Cannabinoid Receptor 2 Using a Multi-Step Virtual Screening Strategy
por: Mukuo Wang, et al.
Publicado: (2021) -
COMPUTATIONAL INVESTIGATION OF METHYL α-D-GLUCOPYRANOSIDE DERIVATIVES AS INHIBITOR AGAINST BACTERIA, FUNGI AND COVID-19 (SARS-2)
por: Kawsar,Sarkar M. A., et al.
Publicado: (2021)